National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry

Ítems similars

• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  per: Martini A, et al.
  Publicat: (2011-09-01)
• Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
  per: Caorsi, R, et al.
  Publicat: (2011)
• The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
  per: Caorsi, Roberta, et al.
  Publicat: (2013)
• 12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
  per: Paloni, G, et al.
  Publicat: (2008)
• P02-024 - Clinical impact of V198M mutation in NLRP3 gene
  per: Caorsi, R, et al.
  Publicat: (2013)